Table 1.

Patient and tumor characteristics for the complete cohort and per treatment modality.

	Complete Cohort		EBRT +/- HT		Radical Prostatectomy		Brachytherapy		Active Surveillance		Systemic treatment*		Other Treatment
	n	%	n	%	n	%	n	%	n	%	n	%	n	%
Total	161003	100	42069	26.13	27784	17.26	8036	4.99	26083	16.20	39280	24.40	17851	11.09
Median Age (IQR)	70 (64-75)		70.0 (65-75)		64 (59-67)		65 (61-70)		72 (65-77)		74 (67-79)		73 (67-79)
Age Group
<60	19275	11.96	3832	9.11	7442	26.79	1565	19.47	2377	9.11	2830	7.20	1229	6.88
60-69	61191	37.98	16908	40.19	16680	60.03	4304	53.56	8440	32.36	9766	24.86	5093	28.53
70-79	61514	38.18	19999	47.54	3611	13.00	2129	26.49	11081	42.48	16951	43.15	7743	43.38
80+	19123	11.87	1330	3.16	51	0.18	38	0.47	4185	16.04	9733	24.78	3786	21.21
Time Period
1991-1997	27635	19.75	7176	19.71	2403	9.89	101	1.55	2491	11.06	10058	29.23	5406	34.29
1998-2005	49695	35.51	14946	41.04	8016	32.99	2277	34.83	5976	26.54	13657	39.69	4823	30.59
2006-2014	62616	44.74	14295	39.25	13880	57.12	4159	63.62	14050	62.40	10695	31.08	5537	35.12
Second Primary Cancer (SPC)
	22538	100	7654	33.96	4131	18.33	1338	5.94	3543	15.72	3435	15.24	2437	10.81
Disease Stage
T1-2 N0/X, M0/X	111456	69.18	27071	64.35	26187	94.25	7940	98.81	24140	92.55	11882	30.25	14236	79.75
T3 N0/X, M0/X	20002	12.42	12172	28.93	1312	4.72	85	1.06	1155	4.43	4293	10.93	985	5.52
T4 or N+ or M+	29645	18.40	2826	6.72	285	1.03	11	0.14	788	302	23105	58.82	2630	14.73
Median time between PCa diagnosis and SPC (years)	5.81		6.04		7.36		6.65		5.27		4.16		5.54

External beam radiotherapy with/without hormonal therapy (EBRT +/- HT), *Systemic treatment mainly concerns hormonal therapy only.